Icahn makes new bet on Allergan in second-quarter: filing
Reuters
Published Aug 16, 2016 10:42AM ET
Icahn makes new bet on Allergan in second-quarter: filing
BOSTON (Reuters) - Carl Icahn, the octogenarian investor whose stock investments still create a buzz on Wall Street nearly 50 years after he first got into the business, made a new bet on Allergan (NYSE:AGN_pa), a new filing shows.
Icahn who invests his personal fortune estimated by Forbes to be roughly $17 billion largely kept his portfolio unchanged, reporting no change on his investments in Cheniere Energy, Freeport-McMoRan and Herbalife (NYSE:HLF) during the second quarter.
But he did make one significant addition when he bought 3.4 million shares of drugmaker Allergan, valued at $785.7 million.
Icahn kept his holding in Hertz Global Holdings Inc mostly unchanged, but the share count was lower after the company issued a 5-for-1 reverse stock split on the last trading day of the second quarter.
Icahn like other investors on Monday filed a so-called 13-F filing that shows what U.S. stocks he owned at the end of the second quarter.
He made smaller adjustments to his biggest holdings including a 2 percent hike in AIG, bringing his ownership to 45.6 million shares. PayPal Holdings, was cut by 10 percent to 33.9 million shares, the filing shows.
Icahn, like some other billionaire investors, has made big bets on energy companies, betting on a recovery that has been spotty so far.
Allergan's stock price dropped 14 percent during the second quarter after Pfizer (NYSE:PFE) walked away from a planned merger, but some investors expect that Allergan will tie up with another company, suggesting that the stock price will rebound.
(Corrects headline, first and third paragraphs to show no change in Hertz Global Holdings, adds that cut in shares was related to reverse stock split)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.